Antex Biologics Inc., of Gaithersburg, Md., appointed Jeffrey Pirone executive vice president and chief financial officer...Elitra Pharmaceuticals Inc., of San Diego, appointed Martin Rosenberg to its board and scientific advisory board and Philip Youngman vice president of discovery biology

and Carolyn Martin vice president, field operations of the Americas...Diana Hablitz coordinator, preclinical and clinical development

Interleukin Genetics Inc., of Waltham, Mass., named Nazneen Aziz medical director and Raju Govindaraju director of statistical genetics, both in the department of clinical research and development...Ladenburg Thalmann, of New York, added Albert Rauch and Edward Nash as senior health care equity research analysts

Beckman Coulter Inc., of Fullerton, Calif., formed three divisions and named a president of each...MitoKor, of San Diego, appointed Jerry Weisbach to its board and Barry Wolitzky vice president of preclinical research and development...Origenix Technologies Inc., of Montreal, elected Michael Atkin and Barry Markowsky to its board

Jerome Birnbaum, Stephen Carter and Prasad Sunkara will serve as consultants on its preclinical and clinical development advisory panel...Limber is president and CEO of Aclara BioSciences Inc., of Mountain View, Calif

Avidex Ltd., of Oxford, UK, appointed Peter Doyle and Alan Rosenthal nonexecutive directors...and Premchandran Ramiya director of process research and development

Centaur Pharmaceuticals Inc., of Sunnyvale, Calif., added Dushyant Pathak as senior vice president of business development and strategic planning and Philip James as vice president of clinical development...and Jerry Weisbach, former president of the Parke Davis Research Division, Warner-Lambert Co

plc, of Dublin, Ireland, named Lars Ekman president, research and development, Elan Pharmaceuticals...and Motohiro Ueda president & representative director, Elan Pharma K.K., Japan...Immunex Corp., of Seattle, promoted Daniel Burge to vice president of clinical development

and added Eliel Bayever, William Freimuth and Ann Wang to its clinical development group

AVI BioPharma Inc. , of Portland, Ore., hired David Mason as its senior vice president of clinical development and regulatory affairs...It also appointed John Skolas chief financial officer and corporate vice president, Jean-Marie Vallet president of human health care and corporate vice president, and Martin Reese director of informatics discovery

and Scott Rollins to vice president, drug development and project management...Howson is the former senior vice president and director, worldwide business development, at SmithKline Beecham

Desmond-Hellman is executive vice president and chief medical officer of Genentech Inc...Immunex Corp., of Seattle, said Leslie Garrison will lead its clinical development programs as senior vice president, clinical development

AnorMED Inc., of Vancouver, British Columbia, named Gary Calandra vice president of clinical development...MGI Pharma Inc., of Minneapolis, named Michael Cullen vice president, clinical affairs, and chief medical officer

Variagenics Inc., of Cambridge, Mass., named Alan C. Houston chief medical officer and vice president of clinical development...Zycos Inc., of Lexington, Mass., added Daniel Green and Arda Mincherhomjee as board members

Techno Venture Management, of Munich, Germany, promoted Gert Caspritz and Peter Levin to partners...Warner Chilcott plc, of Dublin, Ireland, named Herman Ellman senior vice president, clinical development

Aviron, of Mountain View, Calif., named Charlene Friedman vice president and general counsel...Discovery Laboratories Inc., of Doylestown, Pa., named Timothy Gregory senior director, clinical development and administration...It also named Robert Touslee vice president and chief intellectual property officer

Pharma Mar SA, of Madrid, Spain, named Immaculada Abella and Jose Sanchez-Puelles heads of marketing and discovery...GlycoDesign Inc., of Toronto, appointed Leonard Walt vice president, clinical development and regulatory affairs

and Florence Wambugu, director of the International Service for the Acquisition of Agri-biotech Applications in Nairobi, Kenya...Immunex Corp., of Seattle, named Mark Booth senior vice president and general manager for Enbrel, and Richard Stead vice president clinical development

It also promoted Daniel Levangie, Joseph Kelly and Ted Geiselman to senior vice president...Simon Tomlinson vice president, and general manager for the European office in Munich, Germany...and Karl Thiel editor in chief of DoubleTwist.com